Use of immunological studies in evaluating the clinical course of nasopharyngeal carcinoma
- PMID: 215534
Item in Clipboard
Use of immunological studies in evaluating the clinical course of nasopharyngeal carcinoma
IARC Sci Publ (1971).
1978.
Abstract
The prognosis of a NPC patient is influenced by many factors, including the therapeutic method used and the clinical stage and histological characteristics of the tumour. The immune response of the peripheral lymphocytes was examined in 27 patients with NPC, and it was concluded that this response accurately indicates the clinical course of the diseases as compared with clinical stage of disease, histological type of tumour and anti-VCA-antibody titre.
Similar articles
-
Nasopharyngeal carcinoma. VII. B and T lymphocytes in the circulating blood and in tumour tissue.Biomedicine. 1974 Jun 10;21(6):244-50. Biomedicine. 1974. PMID: 4374264 No abstract available.
-
General immunological status of nasopharyngeal carcinoma patients in Singapore.IARC Sci Publ (1971). 1978;(20):495-501. IARC Sci Publ (1971). 1978. PMID: 215531
-
Histological typing of nasopharyngeal carcinoma.IARC Sci Publ (1971). 1978;(20):3-12. IARC Sci Publ (1971). 1978. PMID: 215516
-
[The diagnosis of nasopharyngeal carcinoma (author's transl)].HNO. 1980 Aug;28(8):247-60. HNO. 1980. PMID: 6254933 Review. German.
-
[Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].Bull Cancer Radiother. 1996;83(1):3-7. Bull Cancer Radiother. 1996. PMID: 8679277 Review. French.